Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
Short Bowel Syndrome Market
The Short Bowel Syndrome Market size was valued at USD 805.0 million in 2018 to USD 1,226.6million in 2024 and is anticipated to reach USD 2,446.0 million by 2032, at a CAGR of 9.28% during the forecast period.
Primary Biliary Cholangitis (PBC) Treatment Market
The Primary Biliary Cholangitis (PBC) Treatment Market size was valued at USD 872.9 million in 2018 to USD 1,333.5 million in 2024 and is anticipated to reach USD 2,333.1 million by 2032, at a CAGR of 7.26% during the forecast period.
Asthma And COPD Drugs Market
The Asthma and COPD Drugs Market size was valued at USD 15,713.5 million in 2018 to USD 20,517.7 million in 2024 and is anticipated to reach USD 28,332.8 million by 2032, at a CAGR of Z% during the forecast period.
Antioxidants Market
The Global Antioxidants Market size was valued at USD 3,508.85 million in 2018 to USD 5,052.13 million in 2024 and is anticipated to reach USD 8,111.80 million by 2032, at a CAGR of 5.68% during the forecast period.
Antidiabetics Market
The Global Antidiabetics Market size was valued at USD 49,255.25 million in 2018 to USD 86,062.60 million in 2024 and is anticipated to reach USD 1,89,645.41 million by 2032, at a CAGR of 9.67% during the forecast period.
Hypercholesterolemia Drugs Market
The Hypercholesterolemia Drugs market size was valued at USD 8,855.2 million in 2018, increased to USD 15,361.0 million in 2024, and is anticipated to reach USD 28,999.5 million by 2032, at a CAGR of 8.23% during the forecast period.
Cancer Biomarkers Market
The Cancer Biomarkers market size was valued at USD 14,646.2 million in 2018, increased to USD 24,567.0 million in 2024, and is anticipated to reach USD 48,248.0 million by 2032, at a CAGR of 8.83% during the forecast period.
Atopic Dermatitis Treatment Market
The Global Atopic Dermatitis Treatment Market is projected to grow from USD 15,461.3 million in 2024 to an estimated USD 34,623.2 million by 2032, with a compound annual growth rate (CAGR) of 10.66% from 2025 to 2032.
Hepatitis C Treatment Market
The Global Hepatitis C Treatment Market is projected to grow from USD 8,698.4 million in 2024 to an estimated USD 11,737.4 million by 2032, with a compound annual growth rate (CAGR) of 3.80% from 2025 to 2032.
Hemophilia Treatment Market
The Global Hemophilia Treatment Market is projected to grow from USD 28,437.5 million in 2024 to an estimated USD 87,015.4 million by 2032, with a compound annual growth rate (CAGR) of 15.03% from 2025 to 2032.
